魏继业

魏继业-内页.jpg

  魏继业,男,1965年6月出生,前新加坡国立健康研究院(A*STAR)新生血管项目所长,美国爱尔康(Alcon)眼科制药厂资深科学家,美国爱立健(Allergan)大药厂主任级研究员,2012年诺华制药(Novartis)研究院创新奖获得者。旅美生活及工作20多年,在美国和新加坡著名的大学及国际跨国公司担任领导职位。博士毕业于中国科学院上海生理所,师从杨雄里院士。毕业后,随即赴美在耶鲁大学医学院眼科从事严格的博士后训练,并因成绩突出,三年后升任副研究员,独立主持自己的实验室。

  专业领域:眼科疾病的药物治疗及眼科医疗器械,研究方向是老年黄斑变性,糖尿病眼底病变,青光眼及干眼症的治疗的发明及产品的创新及开发。

  主要成果:从事眼科疾病机理和新药开发的研究。承担美国国立卫生研究院(NIH)和跨国制药企业科研项目10余项,已在国际知名杂志发表论文20余篇,美国专利2个。


Dr Jay Wei is responsible for managing SERI-IMCB program in retinal angiogenic diseases(SIPRAD) a team of clinicians, scientists,research fellows, laboratory and clinical staff , His main research interests are aged-related macular degeneration and diabetic retinopathy. He was Pricipal Scientist of Department of Biological Sciences,Allergan, California. Prior to Allergan, Dr Wei was scientific leader of Intrexon Ophthalmic Division,Gemantown, Maryland.Dr Wei also worked at Alcon Laboratories,Fort Worth, Texas for 10 years and Novartis Institute of Biomedical Research (NIBR) for 2 years as key Senior Scientist of Degenerative Diseases and Retinopathy program. He received his medical training form Binzhou Medical University ,Shandong Province,China, attained his master degree in physiology from Xi’an Jiaotong University Medical Center ,and a PhD in retianl biology from Chinese Academy of Science,Shanghai,China.After graduation, he moved to United States to complete his posidoctoral training in retinal biology from Department of Ophthalmology and Visual Science, Yale University School of Medicine. From 1998 to 2001, he was a research junoir faculty in the sarne department at Yale. Dr Wei has nearly 25 years of experience in retinal biology studies,including 14 years industry experience and 11 years academic experience in various retinal programs.He received the Novartis NIBR Spotlight Award in 2012.